Clinical Trial Update: ADMA Levels in End-Stage Renal Disease

View source ↗

Summary

A completed clinical trial examining the levels of asymmetric dimethylarginine (ADMA) in patients with end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Snippet

Sponsor: University of Michigan | Conditions: Chronic Kidney Disease, Hypertension | Status: COMPLETED